TAEK-VAC-HerBy
- Generic Name
- TAEK-VAC-HerBy
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer
Phase 1
Completed
- Conditions
- ChordomaHER2-positive Breast Cancer
- Interventions
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Bavarian Nordic
- Target Recruit Count
- 37
- Registration Number
- NCT04246671
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Mayo Clinic - Phoenix, Scottsdale, Arizona, United States
🇺🇸Providence Saint John's Health Center, Santa Monica, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath